Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Psychopharmacology|October 16, 2009
Light and intermittent cigarette smokers: a review (1989-2009)Chris R E Coggins, E Lenn Murrelle, Richard A Carchman, et al.
Journal of Correctional Health Care : the Official Journal of the National Commission on Correctional Health Care|February 4, 2026
Medications for Opioid Use Disorder in Correctional Facilities: A 2022 Cross-Sectional Survey of Health Care StaffClaire Wolfe, Sabrina Gaiazov, Pamela Valera, et al.
The Journal of Sexual Medicine|February 12, 2009
Delay of ejaculation induced by SB-277011, a selective dopamine D3 receptor antagonist, in the ratPierre Clément, Chiara Pozzato, Christian Heidbreder, et al.
Journal of Addictive Diseases|October 10, 2014
A randomized, double-blind, placebo-controlled trial of RBP-8000 in cocaine abusers: pharmacokinetic profile of rbp-8000 and cocaine and effects of RBP-8000 on cocaine-induced physiological effectsAzmi F Nasser, Paul J Fudala, Bo Zheng, et al.
Journal of Clinical Pharmacology|October 20, 2015
Population Pharmacokinetic Modeling After Repeated Administrations of RBP-6000, a New, Subcutaneously Injectable, Long-Acting, Sustained-Release Formulation of Buprenorphine, for the Treatment of Opioid Use DisorderCeline M Laffont, Roberto Gomeni, Christian Heidbreder, et al.
Biomedical Chromatography : BMC|July 9, 2016
Quantitative determination of buprenorphine, naloxone and their metabolites in rat plasma using hydrophilic interaction liquid chromatography coupled with tandem mass spectrometryAnand Joshi, Brian Parris, Yongzhen Liu, et al.
Behavioural Pharmacology|February 3, 2011
Orexin-1 receptor antagonist SB-334867 reduces the acquisition and expression of cocaine-conditioned reinforcement and the expression of amphetamine-conditioned rewardDaniel M Hutcheson, Davide Quarta, Briac Halbout, et al.
Lasers in Surgery and Medicine|February 3, 2004
Autofluorescence spectrofluorometry of central nervous system (CNS) neuromediatorsFrancesco Crespi, Anna C Croce, Sabrina Fiorani, et al.
Neurochemistry International|January 3, 2009
Systemic administration of ghrelin increases extracellular dopamine in the shell but not the core subdivision of the nucleus accumbensDavide Quarta, Carla Di Francesco, Sergio Melotto, et al.
Cureus|November 25, 2025
Post-marketing Surveillance of Intranasal Nalmefene: Prevalence and Clinical Relevance of Precipitated WithdrawalJordan Paavola, Phil Skolnick, Ann Wheeler, et al.
Pageof 7